Abstract:Mitochondria are the main cellular energy powerhouses and supply most of the energy in the form of ATP to fuel essential neuronal functions through oxidative phosphorylation (OXPHOS). In Alzheimer disease (AD), metabolic and mitochondrial disruptions are an early feature preceding any histopathological and clinical manifestations. Mitochondrial malfunction is also linked to synaptic defects in early AD. Mitophagy serves as a key cellular quality control mechanism involving sequestration of damaged mitochondria within autophagosomes and their subsequent degradation in lysosomes. However, it remains largely unknown whether mitophagy is involved in the regulation of energy metabolism in neurons, and if so, whether metabolic deficiency in AD is attributed to mitophagy dysfunction. Here we reveal that mitophagy is broadly activated in metabolically enhanced neurons upon OXPHOS stimulation, which sustains high energetic activity by increasing mitochondrial turnover and hence facilitating mitochondrial maintenance. Unexpectedly, in AD-related mutant HsAPP Tg mouse brains, early stimulation of OXPHOS activity fails to correct energy deficits but exacerbates synapse loss as a consequence of mitophagy failure. Excitingly, lysosomal enhancement in AD neurons restores impaired metabolic function by promoting elimination of damaged mitochondria, protecting against synaptic damage in AD mouse brains. Taken together, we propose a new mechanism by which mitophagy controls bioenergetic status in neurons, furthering our understanding of the direct impact of mitophagy defects on AD-linked metabolic deficits and shedding light on the development of novel therapeutic strategies to treat AD by the early stimulation of mitochondrial metabolism combined with elevation of lysosomal proteolytic activity.Abbreviations: AD: Alzheimer disease; Aβ: amyloid-β; APP: amyloid beta precursor protein; AV: autophagic vacuole; CHX: cycloheximide; CYCS: cytochrome c, somatic; DIV: days in vitro; FRET: Förster resonance energy transfer; Gln, glutamine; LAMP1: lysosomal associated membrane protein 1; LE: late endosome; Mito: mitochondria; Δψm: mitochondrial membrane potential; OCR: oxygen consumption rate; OXPHOS: oxidative phosphorylation; SQSTM1/p62: sequestosome 1; RHEB: Ras homolog, mTORC1 binding; ROS: reactive oxygen species; STX1: syntaxin 1; SYP: synaptophysin; Tg: transgenic; TMRE: tetramethylrhodamine ethyl ester; TEM: transmission electron microscopy; WT: wild type.

Role of the AMPK pathway in promoting autophagic flux via modulating mitochondrial dynamics in neurodegenerative diseases: Insight into prion diseases

FBXW7-Induced MTOR Degradation Forces Autophagy to Counteract Persistent Prion Infection

Role of autophagy in prion protein-induced neurodegenerative diseases.

Activation of the Ampk-Ulk1 Pathway Plays an Important Role in Autophagy During Prion Infection

The Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion Diseases

p62-Keap1-NRF2-ARE Pathway: A Contentious Player for Selective Targeting of Autophagy, Oxidative Stress and Mitochondrial Dysfunction in Prion Diseases

Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases with Focus on Prion Diseases

AMPK-mediated regulation of neuronal metabolism and function in brain diseases

Mitophagy in Neurodegenerative Disease Pathogenesis

Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

How Ampk and Pka Interplay to Regulate Mitochondrial Function and Survival in Models of Ischemia and Diabetes

[Research progress in the regulation of autophagy and mitochondrial homeostasis by AMPK signaling channels]

AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases

The Role of Mitophagy in the Regulation of Mitochondrial Energetic Status in Neurons

PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process

Autophagy and apoptosis dysfunction in neurodegenerative disorders

The Multiple Roles of Autophagy in Neural Function and Diseases

Brain-specific repression of AMPK1 alleviates pathophysiology in Alzheimer's model mice

Mitophagy Regulates Neurodegenerative Diseases

Autophagy and ALS: mechanistic insights and therapeutic implications